Newest first. 5.2k questions across 107 tags.
Conditions: 15 mg · tirzepatide. I want to know whether this is a real physical effect or an artefact of how it is measured. What prompted the question is an…
Concretely: semaglutide · 37 °C · twenty-one days. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would…
For reference: tirzepatide · 4 mg/mL. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping rules,…
The specifics, since they change the answer: 25 units · 10 mg/mL. I want a method I can write down and repeat, not a rule of thumb. I would rather over-engineer this…
For reference: 97.1% · ecnoglutide. I would rather understand the derivation than memorise the outcome. Two people I asked gave two answers that differ by a factor of…
What I am working with: retatrutide · eight weeks · 4 °C. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me suspicious.…
Stated plainly: nausea · a GLP-1 receptor agonist · STEP 8. I would like help reading this properly rather than being told what conclusion to reach. I have the full…
Stated plainly: STEP 1 · vomiting · 2 mg. I would like help reading this properly rather than being told what conclusion to reach. I have the full report including…
What I have: FGP · Nantong Guangyuan Chemical. Both of these get recommended confidently by different people, which suggests neither is obviously right. My…
The method section is present, which is unusual enough that I want to make use of it. This is a procedural question rather than a theoretical one, and I would like…
Stated plainly: 10 mg/mL · a GLP-1 receptor agonist. Both of these get recommended confidently by different people, which suggests neither is obviously right. My…
The specifics, since they change the answer: purity figure · JEEP. I would like to set this up properly once, rather than adjust it repeatedly. My budget is real but…
Details up front: a GLP-1 receptor agonist · 4 mg/mL. I would like to understand the steps well enough to explain them to someone else. I have access to a…
Details up front: hydrolysis · orforglipron · VendorInvestigate. I would like to understand the steps well enough to explain them to someone else. I have access to a…
Conditions: 97.1% · VendorInvestigate · 95.2%. I think I have a problem. I am not yet sure whether it is a real problem or a measurement artefact. I want to know…
Concretely: ecnoglutide · 5 mg/mL. I want the working, not the result — I need to be able to redo it with different numbers. I care about the precision as well as the…
Conditions: HJ · Zhuhai Kerui Biotechnology. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to know that, so I…
The specifics, since they change the answer: AST · ten weeks · a GLP-1 receptor agonist. Something has gone wrong and I would like to know how badly before I decide…
The particulars: 97.1% · semaglutide. I would like the arithmetic checked rather than the conclusion asserted. I have deliberately not used an online calculator…
I am reading the trial table rather than the press release, which is why the numbers differ. I understand the observation; what I do not understand is the mechanism…
The specifics, since they change the answer: STEP 5 · semaglutide. I would like to know whether this claim survives contact with evidence. If the answer is "nobody…
The specifics, since they change the answer: 15 mg · 6.67 mg/mL. I would like the arithmetic checked rather than the conclusion asserted. I have deliberately not used…
What I have: SSA · Wuhan · Sweden. I am at the decision point and I would rather think it through than improvise. I would rather spend money on measurement than on…
For reference: 5 mg · ten weeks · injection-site erythema. I understand the observation; what I do not understand is the mechanism behind it. I have read the two…